ILMN Jan 2025 350.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.0000

0.0000

(0.00%)

As of 10:30AM EDT. Market open.

Loading interactive chart…

Zacks
Analysts Estimate AbCellera Biologics Inc. (ABCL) to Report a Decline in Earnings: What to Look Out for
AbCellera Biologics (ABCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Gear Up for Illumina (ILMN) Q1 Earnings: Wall Street Estimates for Key Metrics
Evaluate the expected performance of Illumina (ILMN) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Zacks
Illumina (ILMN) Expected to Beat Earnings Estimates: Should You Buy?
Illumina (ILMN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.